http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201718637-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_872dd7cd609eb2a937dcfd303d521798
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B30-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B50-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B40-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531
filingDate 2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27ef2bf52cdad2e8112a05460c9898c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce409a7558cef66740826595f00daec4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5c18d57ca1c3520650b2afcffbab217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e8a520161c421a76c20c250a25cfab1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93358dcbffffa693484369ac454a45a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf1b8dee5929109f27cf52e4354c9fda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69e5a8c1c780b2b7dd133a3c05fb8a12
publicationDate 2017-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-201718637-A
titleOfInvention Antibody variant
abstract The present invention relates to methods of selecting, screening, engineering, manufacturing, and modifying antibodies that have improved bioavailability when administered to humans by subcutaneous administration. The invention also describes antibodies and variant antibodies having improved bioavailability when administered to humans by subcutaneous administration.
priorityDate 2015-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49371
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCR4J7Z9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCI0CME7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554042
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586576
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475141
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CH89
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID406146
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86687
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HKM3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ08169
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9541
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID174383
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB3EWP2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCI0CME8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCW0HFN9
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9541
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP85841
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9U6V9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86875
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCJ3S820
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38532
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA3QVN6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA3QVN2

Total number of triples: 54.